ActiveNANCT05747703

A Telehealth Intervention to Increase Screening and Treatment for Alcohol Use Disorder

Sponsor: Ria Health

Trial Details

Condition	Alcohol Use Disorder, Alcohol Dependence, Alcoholism
Intervention	Ria Treatment Platform
Phase	NA
Status	Active
Participants	135
Est. Completion	21 Apr 2026
Last Updated	30 June 2026

Primary Outcome

Percent of subjects without heavy drinking days

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * alcohol use disorder Exclusion Criteria: * inability to provide informed consent

Trial Sites

Countries

United States

View Registry Entry

Related Analysis

Telehealth vs Waitlist: Randomised Trial of the Ria Platform for Alcohol Use Disorder Targets Heavy Drinking Reduction — Key Findings Expected 2026

A randomised controlled trial of the Ria Treatment Platform — a telehealth intervention combining pharmacotherapy, coaching, and Bluetooth breathalyser monitoring — is evaluating its impact on heavy drinking days in adults with alcohol use disorder. With results expected by April 2026, the trial could provide pivotal evidence for scalable digital AUD care. Australian clinicians should monitor outcomes closely as the TGA continues to develop its regulatory framework for digital health technologies.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service